ATLAS students turn research evidence into practical tools and policy
recommendations for public health decision makers. Our advocacy work
runs alongside our research, so each project moves from what the
evidence shows to what health systems can do about it.
Our aims
Nationwide reach
We aim to bring our tools and recommendations to communities across the
United States, wherever the evidence shows gaps in prevention, early
diagnosis, and access to care.
New York City focus
Our primary partnership work is in New York City, where our director is
based and can work directly with local health departments, clinics, and
community organizations.
A direct liaison
Janvi Garg serves as the liaison between ATLAS students and public
health partners, presenting student work and coordinating every
collaboration.
Interested in partnering with our advocacy teams? Contact Janvi Garg at
ijanvgarg@gmail.com.
AI Diabetes and Skin Cancer Screening
Project leaders: Twesha Singh and Ritvika Perla
Team members: Soham Gupta, Shivam Loyalka, Pranjal Sabuwala,
Rithvika Venkatraman, Swaroop Kadiyam
AI screening tools for diabetic retinopathy and skin cancer can bring
specialist level detection into primary care, but only if they reach the
communities that need them most. This project identifies where those
tools would do the most good in Dallas County and builds the case for
putting them there.
Featured tool: DFW Health Atlas
The team built an interactive map of the Dallas Fort Worth area that
brings together diabetes burden, social vulnerability, clinic and care
locations, shortage areas, and specialty access in one place. The map
was built by Swaroop Kadiyam.
Open
the DFW Health Atlas
Deliverables
- Interactive access map. A tract or ZIP level map of
Dallas County showing diabetes burden, social vulnerability (SVI),
clinic locations, shortage areas, and specialty access indicators.
- AI Screening Equity Index. A composite score
ranking neighborhoods by disease burden, vulnerability, and access
barriers.
- Policy brief. A two to four page summary of
findings, evidence, and recommendations.
- Pilot site recommendation. The top three to five
community areas or clinic catchment areas for an initial pilot.
- Workflow proposal. A screen to specialist pathway
for diabetic retinopathy and suspicious skin lesions.
- Cost benefit scenario calculator. Conservative,
base, and optimistic scenarios built on transparent assumptions.
Cardiovascular Disease Prediction
Project leaders: Sriram Siva and Gokul Kiliparthi
Team members: Dhilan Avula, Srikrithi Appikatla, Neha Manikandan,
Rhea Jha, Samhithaa Sivakumar, Tanvi Chakka, Venkat Narra, Abhikarthi
Appikatla
Standard cardiovascular risk models leave out many of the social and
psychosocial factors that shape who actually develops heart disease and
who gets preventive care. This project turns a 40 study evidence review
into a screening tool and an implementation plan that connects high risk
patients to prevention.
Deliverables
- Define the evidence gap: CVD Prediction Evidence
Brief. A one to two page summary of the 40 study review showing
that standard predictors remain central, socioeconomic and psychosocial
factors are underused, and machine learning often offers only modest
gains.
- Build the tool: CVD Risk and Access Check. A one
page patient and clinic screening tool that pairs conventional risk
assessment with access barriers such as transportation, food access,
language needs, missed appointments, and stress.
- Design the workflow: Screen to Prevention Workflow.
A clear process from high CVD risk identification to an access barrier
screen, referral, and follow up.
- Make the policy case: Clinic and Payer Implementation
Proposal. A two to three page proposal for a community clinic,
Medicare Advantage plan, or Medicaid program describing where the tool
should be piloted, who should receive it, and the safeguards needed for
implementation.